trial

Improving Medication Adherence Among People With Schizophrenia Through the Use of 2-way Pagers

NCTId NCT00392236
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 55 (actual)
Sponsored by Northwell Health, Early Treatment Program at Lenox Hill
Primary completion 2009-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
55 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2006-04
Primary completion
2009-12
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
2-way pager

Sponsors

Northwell Health, Early Treatment Program at Lenox HillLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Investigators

1
Delbert G. Robinson, MDPrincipal Investigator

Sites

1 total
Glen Oaks, United States

Facts & assertions

4 sourced
Enrollment
55
Phase
NA
Primary Completion Date
2009-12
Status
COMPLETED
relationships
The graph out of here
drug
2-way pager
drug
lead_sponsor
Northwell Health, Early Treatment Program at Lenox Hill
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Schizophrenia
indication
Schizophrenia
indication
Psychotic Disorders
indication
investigator
Delbert G. Robinson, MD
person